EUTM file information

018651345

WITEMPO


February 8, 2022

Trademark Summary

The trademark application WITEMPO was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on February 14, 2022, and it was registered by office on May 24, 2022 without any oppositions.

The application was filed in English (German was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations and substances for use in oncology and Pharmaceutical preparations and substances for the treatment of cancer..